| TMQ | Trimetrexate |
|---|---|
| TMTX | Trimetrexate |
| trimetrexate | <drug> An antibiotic approved as an alternative treatment for moderate-to-severe PCP. Trimetrexate causes severe bone marrow, liver, kidney and gastrointestinal toxicities. It must be administered along with leucovorin (folinic acid) to ameliorate these adverse effects. (19 Jan 1998) |
|---|
Synonyms : CI-898, Ipsen Brand of Trimetrexate, JB-11, NSC-249008, NSC-328564, Trimetrexate Hydrate, Trimetrexate Monohydrate, Monoacetate, CI 898, CI898, Hydrate, Trimetrexate, JB 11, JB11, Monohydrate, Monoacetate Trimetrexate, NSC 249008, NSC 328564, NSC249008, NSC328564
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
´ºÆ®·º½ÅÁÖ»ç25mg - »õâ
|
½¦¸µÇª¶ó¿ìÄÚ¸®¾Æ |
E04060161 | Trimetrexate | Àü¹®ÀǾàǰ | »èÁ¦ |
| trimetrexate |
a folic acid antagonist structurally related to methotrexate; it competitively inhibits dihydrofolate reductase. Used investigationally as an antineoplastic; also used in combination with leucovorin to treat Pneumocystis carinii pneumonia in acquired immunodeficiency syndrome, administered intravenously as the glucuronate salt.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|